跳至主要内容
临床试验/JPRN-UMIN000018268
JPRN-UMIN000018268招募中未知

Clinical investigation of change of bone-related marker between denosumab and zoledronic acid in patients with treatment-naive,bone-metastasis prostate cancer:prospective, multiinstitutional,cohort study - Comparative study between denosumab and zoledronic acid in terms of bone marker

Department of Renal and Urologic Surgery, Asahikawa Medical University0 个研究点目标入组 50 人开始时间: 2015年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
40years-old 至 90years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • history of radiation therapy to bone metastasis, history of dental treatment within 6 weeks of entry,Grade 4 renal insuffuciency such as eGFR under 30 or serum creatinine over 3

研究者

发起方
Department of Renal and Urologic Surgery, Asahikawa Medical University

相似试验

Clinical investigation of change of bone-related... | 临床试验